I've been an engineer for about 30 years and I find KB's specifications VERY sensible. Half my career is managing requirements versus expectations and I've done enough management of technical projects to really appreciate that KB set certain non-negotiable stakes in the ground but left the options open for some creativity. If someone came in with a blockbuster idea then it had a chance of being accepted but, barring that, the parameters were simple and set in stone. I'm looking forward to the FDA seeing the beauty in this approach and giving its interim approval and I am confident that this will come to fruition in that case. Even if it doesn't go that way the glucose products are gaining momentum and will be profitable shortly. I'm still betting on this horse (jockey?). Go get 'em, KB.